Gilead

The US drugmaker seeks to boost its cancer drug pipeline

[WASHINGTON] The US Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug remdesivir for treating patients hospitalised with Covid-19, making it the first and only dr...

[SWITZERLAND] Gilead Sciences has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not help patients who have been admitted to hospit...

[BRUSSELS] Gilead Sciences said on Thursday it had agreed to sell Europe up to 500,0000 courses of its antiviral drug remdesivir, as the continent scrambles to shore up supplies of one of only two dru...

[BENGALURU] Gilead Sciences will acquire biopharmaceutical company Immunomedics for US$21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two compa...

[BENGALURU] Gilead Sciences said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 pa...

[BENGALURU] Australia has granted provisional approval to Gilead Sciences's remdesivir as the first treatment option for Covid-19 in the country, the Therapeutic Goods Administration (TGA) said on Fri...

[BRUSSELS] The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe Covid-19 patients following an accelerated review process, making it t...

GILEAD Sciences said it will charge the US government and other developed countries US$390 per vial for its coronavirus-fighting drug Remdesivir, or about US$2,340 for a typical five-day course of tre...